Immunotherapy Reverses Multiple Sclerosis in Mice
More information will be released soon
Hoffman noted that he and his team “are actively developing additional vectors that target several other neuroproteins to have a complement of vectors that will offer a broader range of coverage in the patient. Hopefully that paper will come out in the next couple of months”.
